Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Germline CDKN2A mutation implicated in predisposition to multiple myeloma.

D Dilworth1, L Liu, A K Stewart

  • 1Departments of Medical Biophysics, Clinical Science, and Medicine, University of Toronto, Toronto, Ontario, Canada.

Blood
|February 26, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma Exchange for Acute Renal Failure of Myeloma-Logical, Yet Ineffective: Plasma Exchange When Myeloma Presents as Acute Renal Failure. A Randomized, Controlled Trial. Ann Int Medicine 143: 777-784, 2005.

Journal of the American Society of Nephrology : JASN·2023
Same author

Myocardial infarction risk is increased by periodontal pathobionts: a cross-sectional study.

Scientific reports·2022
Same author

Metagenomic shotgun sequencing of blood to identify bacteria and viruses in leukemic febrile neutropenia.

PloS one·2022
Same author

The Stickland Reaction Precursor <i>trans</i>-4-Hydroxy-l-Proline Differentially Impacts the Metabolism of Clostridioides difficile and Commensal <i>Clostridia</i>.

mSphere·2022
Same author

Germline Cancer Testing in Unselected Patients with Gastric and Esophageal Cancers: A Multi-center Prospective Study.

Digestive diseases and sciences·2022
Same author

Serum BCMA levels predict outcomes in MGUS and smoldering myeloma patients.

Blood cancer journal·2021

Germline mutations in the CDKN2A gene are linked to melanoma and pancreatic cancer. This study found a CDKN2A mutation in a family with melanoma and multiple myeloma, suggesting a broader role for this gene in cancer predisposition.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Germline mutations in the CDKN2A (p16(INK4A)) tumor suppressor gene are known to predispose individuals to melanoma and pancreatic carcinoma.
  • Murine CDKN2A gene mutations have been shown to predispose BALB/c mice to plasmacytoma.

Observation:

  • A family was identified with a germline CDKN2A mutation present in four individuals with melanoma and one with multiple myeloma.
  • Loss of heterozygosity studies on the multiple myeloma patient's bone marrow revealed loss of the wild-type CDKN2A allele in malignant plasma cells.

Findings:

  • The findings suggest that germline CDKN2A mutations may predispose individuals to a wider spectrum of malignancies than previously recognized.
  • The specific cancer type may be influenced by the patient's genetic background.

Related Experiment Videos

Implications:

  • This research expands the known spectrum of cancers associated with germline CDKN2A mutations.
  • Understanding the role of genetic background in cancer expression is crucial for risk assessment and personalized medicine.